Due to SP140’s ability to enhance STAT1/IRF1 signaling and increase PD-L1 expression in tumor-associated macrophages, it has emerged as a crucial biomarker of immune evasion and predictor of immunotherapy resistance in cancers such as HNSCC and lung cancer. The gene discussed is SP140; the disease is head and neck squamous cell carcinoma.